Evidence map›Paper›PMID 29748630›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2018

Interaction between TSPO-a neuroimmune marker-and redox status in clinical high risk for psychosis: a PET-MRS study.

Sina Hafizi, Tania Da Silva, Jeffrey H Meyer, Michael Kiang, Sylvain Houle, Gary Remington, Ivana Prce, Alan A Wilson, Pablo M Rusjan, Napapon Sailasuta and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Feasibility Study for a Microstrip Transmission Line RF Coil Integrated with a PET Detector Module in a 7T Human MR Imaging System.Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine · 2025
    Article
  4. Article
  5. A Review of Potential Neuroimaging Biomarkers of Schizophrenia-Risk.Journal of psychiatry and brain science · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Sina HafiziResearch Imaging Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Tania Da SilvaResearch Imaging Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Jeffrey H MeyerResearch Imaging Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Michael KiangResearch Imaging Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Sylvain HouleResearch Imaging Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Gary RemingtonDepartment of Psychiatry, University of Toronto, Toronto, ON, Canada.
Ivana PrceResearch Imaging Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Alan A WilsonResearch Imaging Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Pablo M RusjanResearch Imaging Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Napapon SailasutaResearch Imaging Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Romina MizrahiResearch Imaging Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada. romina.mizrahi@camhpet.ca.
University of Toronto · CACentre for Addiction and Mental Health · CA

Funding

Imaging Neuroinflammation in Clinical high risk and SchizophreniaR01MH100043 · NIMH · CENTRE FOR ADDICTION AND MENTAL HEALTH · PI MIZRAHI, ROMINA · 2014 to 2018
$1.6M
NIMH NIH HHS R01 MH100043
6 · The paper itself

Abstract

Altered neuroimmune response and oxidative stress have both been implicated in the pathophysiology of schizophrenia. While preclinical studies have proposed several pathways regarding potential interactions between oxidative stress and neuroimmune imbalance in the development of psychosis, the molecular mechanisms underlying this interaction are not yet understood. To date, no study has investigated this link in vivo in the human brain. We conducted the first in vivo study linking translocator protein 18  kDa (TSPO) expression and glutathione (a major brain antioxidant and a marker for redox status) in the medial prefrontal cortex (mPFC) of a relatively large sample of participants (N = 48) including 27 antipsychotic-naïve individuals at clinical high risk for psychosis and 21 matched healthy volunteers using high-resolution PET with TSPO radioligand, [

Indexed as

AnilidesBrainFemaleGlutathioneHumansMaleOxidation-ReductionPositron-Emission TomographyProdromal SymptomsProton Magnetic Resonance SpectroscopyPsychotic DisordersPyridinesRadiopharmaceuticalsReceptors, GABARiskYoung AdultAnilidesGlutathioneN-(2-((N-(4-phenoxypyridin-3-yl)acetamido)methyl)phenoxy)ethyl fluoridePyridinesRadiopharmaceuticalsReceptors, GABATSPO protein, human

Identifiers

PMID29748630
PMCPMC6006145
OpenAlexW2797924446

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.